Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Appointed director
|
Sensei Biotherapeutics, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/02/2023 |
4
| Cambrian BioPharma Inc (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Disposed/sold 1,587,302 shares
@ $1.26, valued at
$2M
|
|
08/02/2023 |
4
| Peyer James (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Disposed/sold 1,587,302 shares
@ $1.26, valued at
$2M
|
|
07/12/2023 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 4,466 shares
@ $0 Granted 14,550 options to buy
@ $1.22, valued at
$17.8k
|
|
07/12/2023 |
4
| RICKS THOMAS G (Director) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 4,466 shares
@ $0 Granted 14,550 options to buy
@ $1.22, valued at
$17.8k
|
|
07/12/2023 |
4
| Broder Samuel (Director) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 4,466 shares
@ $0 Granted 14,550 options to buy
@ $1.22, valued at
$17.8k
|
|
07/12/2023 |
4
| Humer Kristian (Director) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 4,466 shares
@ $0 Granted 14,550 options to buy
@ $1.22, valued at
$17.8k
|
|
07/12/2023 |
4
| English Jessie (Director) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 4,466 shares
@ $0 Granted 14,550 options to buy
@ $1.22, valued at
$17.8k
|
|
07/12/2023 |
4
| Vojta Deneen (Director) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 4,466 shares
@ $0 Granted 14,550 options to buy
@ $1.22, valued at
$17.8k
|
|
07/12/2023 |
4
| Holmen Bob (Director) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 4,466 shares
@ $0 Granted 14,550 options to buy
@ $1.22, valued at
$17.8k
|
|
07/12/2023 |
4
| Peyer James (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 4,466 shares
@ $0 Granted 14,550 options to buy
@ $1.22, valued at
$17.8k
|
|
07/12/2023 |
4
| Cambrian BioPharma Inc (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 4,466 shares
@ $0 Granted 14,550 options to buy
@ $1.22, valued at
$17.8k
|
|
06/02/2023 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Sold 2,485,923 shares
@ $1.58, valued at
$3.9M
Sold 955,738 shares
@ $1.58, valued at
$1.5M
|
|
02/27/2023 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Bought 1,100 shares
@ $1.615, valued at
$1.8k
Bought 1,100 shares
@ $1.6023, valued at
$1.8k
|
|
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2022 |
4
| English Jessie (Director) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 4,466 shares
@ $0 Granted 14,550 options to buy
@ $2.05, valued at
$29.8k
|
|
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Peyer James (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Bought 1,203 shares
@ $3.2, valued at
$3.8k
|
|
03/01/2022 |
4
| Peyer James (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Bought 42 shares
@ $3.6, valued at
$151.2 Bought 2,458 shares
@ $3.6, valued at
$8.8k
|
|
03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/28/2022 |
4
| Peyer James (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Bought 2,500 shares
@ $3.65, valued at
$9.1k
|
|
02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2022 |
4
| Peyer James (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Bought 2,500 shares
@ $3.8, valued at
$9.5k
Bought 15,000 shares
@ $3.63, valued at
$54.5k
|
|
02/22/2022 |
4
| Peyer James (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Bought 4,949 shares
@ $4.17, valued at
$20.6k
Bought 15,000 shares
@ $3.97, valued at
$59.6k
|
|
02/22/2022 |
4
| Cambrian BioPharma Inc (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Bought 4,949 shares
@ $4.17, valued at
$20.6k
Bought 15,000 shares
@ $3.97, valued at
$59.6k
|
|
02/17/2022 |
4
| Pierce Robert Hamilton (Chief R&D Officer) has filed a Form 4 on Sensei Biotherapeutics, Inc.
Txns:
| Granted 21,000 shares
@ $0 Granted 62,000 options to buy
@ $4.3, valued at
$266.6k
|
|
|
|
|